The government’s cooperating witness in the failed Africa sting prosecution was sentenced today to 18 months in federal prison followed by 36 months probation, according to a courthouse source.
If you’ve read earlier versions, you know it’s packed with useful data and insightful analysis.… Continue Reading
Tropical Singapore is experiencing an outbreak of a different sort — sex and corruption scandals.
Last week, according to Bloomberg’s Andrea Tan, an associate professor at the National University of Singapore was charged with corruption ‘for allegedly trading better grades for sex with a female student.’… Continue Reading
Massachusetts-based Sensata Technologies Holding N.V., part of our Corporate Investigations List, said Friday the DOJ has closed its inquiry but could reopen it if new evidence shows up.
The company said it hasn’t heard any news from the SEC about the investigation.… Continue Reading
Industrial supplier WW Grainger Inc said last week that its internal investigation didn’t substantiate ‘significant use of gift cards for improper purposes in China.’
in March, Illinois-based Grainger said gift-giving practices by employees in China triggered an FCPA investigation.… Continue Reading
Russian anti-corruption activist and opposition leader Alexei Navalny is reportedly facing arrest on Monday for abusing his authority as a volunteer advisor to a regional governor.
It is hard to argue that the current amount of fines is sufficiently “punitive” to deter corporate misconduct given the overall size of the companies engaging in misconduct. Some argue that the answer is just to raise the amount of fines and penalties against companies to draconian levels.… Continue Reading
Houston-based Schlumberger Limited still faces a DOJ investigation for bribes paid to customs officials by global logistics firm Panalpina.
Here’s Michigan-based Stryker Corporation’s full FCPA disclosure from its Form 10-Q filed with the SEC on July 24. The company makes medical devices used for implants and reconstructive procedures.
… Continue Reading
In 2007 we disclosed that the United States Securities and Exchange Commission (SEC) made an inquiry of us regarding possible violations of the Foreign Corrupt Practices Act (FCPA) in connection with the sale of medical devices in certain foreign countries.